南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2014年
3期
368-372
,共5页
刘萃萃%王璐璐%赵卫卫%彭攸%王玉平%孙振亮%冯景
劉萃萃%王璐璐%趙衛衛%彭攸%王玉平%孫振亮%馮景
류췌췌%왕로로%조위위%팽유%왕옥평%손진량%풍경
乳腺癌%EZH2%3'UTR%miRNA%慢病毒文库
乳腺癌%EZH2%3'UTR%miRNA%慢病毒文庫
유선암%EZH2%3'UTR%miRNA%만병독문고
breast carcinoma%EZH2%3' untranslated region%microRNA%lenti-miR virus library
目的:重组过表达EZH2基因3'非翻译区的MCF-7细胞株中筛选靶向miRNAs,并进行细胞和组织定量分析。方法重组细胞株感染慢病毒文库,利用细胞毒性药物筛选后抽提细胞基因组,以此为模板PCR扩增出miRNA前体,测序确定miRNAs名称,并对其进行PCR定量分析。结果在重组细胞株中共筛选出7种miRNAs,依次为miR-15b、miR-16-2、miR-181b2、miR-217、miR-224、miR-329-1、miR-487b,这些新型miRNAs用生物信息学软件PicTar和TargetScan无法预测。Real-time PCR发现,与乳腺癌细胞MCF-7相比,正常乳腺细胞株HBL-100中miR-217、miR-329-1、miR-487b高表达;乳腺癌组织中仅miR-15b及miR-16-2表达增加,与癌旁组织相比差异有统计学意义(P<0.05)。结论在重组过表达EZH23'-UTR的乳腺癌MCF-7细胞株中结合慢病毒文库可筛选出用生物信息学软件未预测的新型靶向miRNAs,这些新型miRNA在正常乳腺细胞与肿瘤细胞及组织中存在差异表达。
目的:重組過錶達EZH2基因3'非翻譯區的MCF-7細胞株中篩選靶嚮miRNAs,併進行細胞和組織定量分析。方法重組細胞株感染慢病毒文庫,利用細胞毒性藥物篩選後抽提細胞基因組,以此為模闆PCR擴增齣miRNA前體,測序確定miRNAs名稱,併對其進行PCR定量分析。結果在重組細胞株中共篩選齣7種miRNAs,依次為miR-15b、miR-16-2、miR-181b2、miR-217、miR-224、miR-329-1、miR-487b,這些新型miRNAs用生物信息學軟件PicTar和TargetScan無法預測。Real-time PCR髮現,與乳腺癌細胞MCF-7相比,正常乳腺細胞株HBL-100中miR-217、miR-329-1、miR-487b高錶達;乳腺癌組織中僅miR-15b及miR-16-2錶達增加,與癌徬組織相比差異有統計學意義(P<0.05)。結論在重組過錶達EZH23'-UTR的乳腺癌MCF-7細胞株中結閤慢病毒文庫可篩選齣用生物信息學軟件未預測的新型靶嚮miRNAs,這些新型miRNA在正常乳腺細胞與腫瘤細胞及組織中存在差異錶達。
목적:중조과표체EZH2기인3'비번역구적MCF-7세포주중사선파향miRNAs,병진행세포화조직정량분석。방법중조세포주감염만병독문고,이용세포독성약물사선후추제세포기인조,이차위모판PCR확증출miRNA전체,측서학정miRNAs명칭,병대기진행PCR정량분석。결과재중조세포주중공사선출7충miRNAs,의차위miR-15b、miR-16-2、miR-181b2、miR-217、miR-224、miR-329-1、miR-487b,저사신형miRNAs용생물신식학연건PicTar화TargetScan무법예측。Real-time PCR발현,여유선암세포MCF-7상비,정상유선세포주HBL-100중miR-217、miR-329-1、miR-487b고표체;유선암조직중부miR-15b급miR-16-2표체증가,여암방조직상비차이유통계학의의(P<0.05)。결론재중조과표체EZH23'-UTR적유선암MCF-7세포주중결합만병독문고가사선출용생물신식학연건미예측적신형파향miRNAs,저사신형miRNA재정상유선세포여종류세포급조직중존재차이표체。
Objective To screen novel miRNAs targeting EZH2 3' untranslated region (UTR) in recombinational MCF-7 breast cancer cells over-expressing EZH2 3' UTR and quantitative analyze the expressions of the screened miRNA in breast cancer cells and tissues. Methods A lentiviral library was transfected into the recombinant cell line MCF-7. The cells were screened with cytotoxic agents before extraction of the genome for amplification of the miRNA precursors using PCR. The screened miRNAs were identified with sequence analysis and their expressions were analyzed quantitatively with real-time PCR in breast cancer cells and tissues. Results Seven miRNAs were screened from the recombinant MCF-7 cells, namely miR-15b, miR-16-2, miR-181b2, miR-217, miR-224, miR-329-1, and miR-487b, all of which failed to be predicted by bioinformatics software. Real-time PCR showed that miR-217, miR-329-1, and miR-487b were over-expressed in MCF-7 cells, and the expression of miR-15b and miR-16-2 was significantly increased in cancer tissues compared with the adjacent tissues (P<0.05). Conclusions Novel targeted miRNAs that can not be predicted by bioinformatics software were successfully screened from MCF-7 breast cancer cells over-expressing EZH2 3' UTR. These miRNAs are expressed differentially between normal breast cells and breast cancer tissues.